Toxoplasmosis during pregnancy: A case report and review of the literature

Hippokratia

Volumn 12, Issue 3, 2008, Pages 139-143

  Giannoulis, C ^a   Zournatzi, B ^a   Giomisi, A ^a,b   Diza, E ^a   Tzafettas, I ^a  

^a ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

^b NONE   (Greece)

Author keywords

Amniocentesis; Cordocentesis; Pregnancy; Toxoplasmosis

Indexed keywords

SPIRAMYCIN;

ADULT; AMNION FLUID; CASE REPORT; CESAREAN SECTION; ECHOGRAPHY; FEMALE; FOLLOW UP; HUMAN; POLYMERASE CHAIN REACTION; PREGNANCY; PREMATURE LABOR; PRENATAL SCREENING; REVIEW; TOXOPLASMOSIS;

EID: 46949086851     PISSN: 11084189     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (46)

1. Montoya G, Liesenfeld O. Toxoplasmosis. Lancet 2004; 363: 1965-1976
2. Gilbert RE, Peckham CS. Congenital toxoplasmosis in the United Kingdom: to screen or not to screen? J Med Screen 2002; 9: 135-141
3. Thiebaut R, Leproust S, Chene G, Gilbert R. Effectiveness of prenatal treatment for congenital toxoplasmosis: a meta-analysis of individual patient's data. Lancet 2007; 369: 115-122
4. Falusi O, French A, Seaberg EC, et al. Prevalence and predictors of Toxoplasma seropositivity in women with and at risk for human immunodefciency virus infection. Clin Infect Dis 2002; 35: 1414-1417
5. Hill D, Dubey P. Toxoplasma gondii: transmission, diagnosis and prevention. Clin Microbiol Infect 2002; 8: 634-640
6. Singh S. Mother-to-child transmission and diagnosis of toxoplasma gondii infection during pregnancy. Indian J Med Microbiol 2003; 21: 69-76
7. Kravetz J, Federman D. Toxoplasmosis in pregnancy. Am J Med 2005; 118: 212-216
8. Montoya J, Rosso F. Diagnosis and management of toxoplasmosis. Clin Perinatol 2005; 32: 705-726
9. Gratzl R, Hayde M, Kohlhauser C, et al. Follow-up of infants with congenital toxoplasmosis detected by polymerase chain reaction analysis of amniotic fuid. Eur J Clin Microbiol Infect Dis 1998; 17: 853-858
10. Berrebi A, Bardou M, Bessieres M, et al. Outcome for children infected with congenital toxoplasmosis in the frst trimester and with normal ultrasound fndings: A study of 36 cases. Eur J Obstet Gynecol Reprod Biol 2007; 135: 53-57
11. Stroehle A, Schmid K, Heinzer I, Naguleswaran A, Hemphill A. Performance of a Western immunoblot assay to detect specifc anti-Toxoplasma gondii IgG antibodies in human saliva. J Parasitol 2005; 91: 561-563
12. Singh M, P Dubey ML, Sud A, Malla N. Antibody response to Toxoplasma gondii in saliva samples from human immunodefciency virus-infected patients. Br J Biomed Sci 2005; 62: 81-84
13. Foulon W, Pinon J, Stray-Pedersen B, et al. Prenatal diagnosis of congenital toxoplasmosis: a multicenter evaluation of different diagnostic parameters. Am J Obstet Gynecol 1999; 181: 843-847
14. Cazenave J, Forestier F, Bessieres M, Broussin B, Begueret J. Contribution of a new PCR assay to the prenatal diagnosis of congenital toxoplasmosis. Prenat Diagn 1992; 12: 119-127
15. Hohlfeld P, Daffos F, Costa JM, Thulliez P, Forestier F, Vidaud M. Prenatal diagnosis of congenital toxoplasmosis with a polymerase-chain-reaction test on amniotic fuid. N Engl J Med 1994; 331: 695-699
16. Hohlfeld P, MacAleese J, Capella-Pavlovski M, et al. Fetal toxoplasmosis: ultrasonographic signs. Ultrasound Obstet Gynecol 1991; 1: 241-244
17. Noordhoek G, van Embden J, Kolk A. Reliability of nucleic acid amplifcation for detection of Mycobacterium tuberculosis: an international collaborative quality control study among 30 laboratories. J Clin Microbiol 1996; 34: 2522-2525
18. Guy E, Pelloux H, Lappalainen M, et al. Interlaboratory comparison of polymerase chain reaction for the detection of Toxoplasma gondii DNA added to samples of amniotic fuid. Eur J Clin Microbiol Infect Dis 1996; 15: 836-839
19. Pelloux H, Guy E, Angelici MC, et al. A second European collaborative study on polymerase chain reaction for Toxoplasma gondii, involving 15 teams. FEMS Microbiol Lett 1998; 165: 231-237
20. Boyer K. Diagnostic testing for congenital toxoplasmosis. Pediatr Infect Dis J 2001; 20: 59-60
21. Warnekulasuriya MR, Johnson JD, Holliman RE. Detection of Toxoplasma gondii in cured meats. Int J Food Microbiol 1998; 45: 211-215
22. Cook A, Gilbert R, Buffolano W, et al. Sources of toxoplasma infection in pregnant women: European multicentre case-control study. European Research Network on Congenital Toxoplasmosis. BMJ 2000; 321: 142-147
23. Foulon W, Naessens A, Derde M. Evaluation of the possibilities for preventing congenital toxoplasmosis. Am J Perinatol 1994; 11: 57-62
24. Boyer K, Holfels E, Roizen N, et al. Risk factors for Toxoplasma gondii infection in mothers of infants with congenital toxoplasmosis: Implications for prenatal management and screening. Am J Obstet Gynecol 2005; 192: 564-571
25. Couvreur J, Desmonts G, Thulliez P. Prophylaxis of congenital toxoplasmosis. Effects of spiramycin on placental infection. J Antimicrob Chemother 1988; Suppl B: 193-200
26. Wallon M, Liou C, Garner P, Peyron F. Congenital toxoplasmosis: systematic review of evidence of effcacy of treatment in pregnancy. BMJ 1999; 318: 1511-1514
27. Daffos F, Forestier F, Capella-Pavlovsky M, et al. Prenatal management of 746 pregnancies at risk for congenital toxoplasmosis. N Engl J Med 1988; 318: 271-275
28. Hohlfeld P, Daffos F, Thulliez P, et al. Fetal toxoplasmosis: outcome of pregnancy and infant follow-up after in utero treatment. J Pediatr 1989; 115: 765-769
29. Berrebi A, Kobuch W, Bessieres M, et al. Termination of pregnancy for maternal toxoplasmosis. Lancet 1994; 344: 36-39
30. McCabe RE, Oster S. Current recommendations and future prospects in the treatment of toxoplasmosis. Drugs 1989; 38: 973-987
31. Georgiev V. Management of toxoplasmosis. Drugs 1994; 48: 179-188
32. Araujo FG, Guptill DR, Remington JS. Azithromycin, a macrolide antibiotic with potent activity against Toxoplasma gondii. Antimicrob Agents Chemother 1988; 32: 755-757
33. Godofsky E. Treatment of presumed cerebral toxoplasmosis with azithromycin. N Engl J Med 1994; 330: 575-576
34. Derouin F, Jacqz-Aigrain E, Thulliez P, Couvreur J, Leport C. Cotrimoxazole for prenatal treatment of congenital toxoplasmosis? Parasitol Today 2000; 16: 254-256
35. Biedermann K, Flepp M, Fierz W, Joller-Jemelka H, Kleihues P. Pregnancy, immunosuppression and reactivation of latent toxoplasmosis. J Perinat Med 1995; 23: 191-203
36. Bachmeyer C, Mouchnino G, Thulliez P, Blum L. Congenital toxoplasmosis from an HIV-infected woman as a result of reactivation. J Infect 2006; 52: e55-e57
37. Porter S, Sande M. Toxoplasmosis of the central nervous system in the acquired immunodefciency syndrome. N Engl J Med 1992; 327: 1643-1648
38. Heitman B, Irizarry A. Recognition and management of toxoplasmosis. Nurse Pract 1997; 22: 79-82
39. Chintana T, Sukthana Y, Bunyakai B, Lekkla A. Toxoplasma gondii antibody in pregnant women with and without HIV infection. Southeast Asian J Trop Med Public Health 1998; 29: 383-386
40. Simpore J, Savadogo A, Ilboudo D, et al. Toxoplasma gondii, HCV, and HBV seroprevalence and co-infection among HIV-positive and -negative pregnant women in Burkina Faso. J Med Virol 2006; 78: 730-733
41. Dunn D, Newell M, Gilbert R. Low risk of congenital toxoplasmosis in children born to women infected with human immunodefciency virus. Pediatr Infect Dis J 1997; 16: 84
42. Minkoff H, Remington JS, Holman S, Ramirez R, Goodwin S, Landesman S. Vertical transmission of toxoplasma by human immunodefciency virus-infected women. Am J Obstet Gynecol 1997; 176: 555-559
43. Helfgott A. TORCH testing in HIV-infected women. Clin Obstet Gynecol 1999; 42: 149-162
44. Vanhems P, Irion O, Hirschel B. Toxoplasmic encephalitis during pregnancy. AIDS 1993; 7: 142-143
45. Conley F, Jenkins K, Remington J. Toxoplasma gondii infection of the central nervous system. Use of the peroxidase-antiperoxidase method to demonstrate toxoplasma in formalin fxed, paraffn embedded tissue sections. Hum Pathol 1981; 12: 690-698
46. Nogueira SA, Guedes AL, Machado ES, et al. Toxoplasmic encephalitis in an HIV infected pregnant woman: successful outcome for both mother and child. Braz J Infect Dis 2002; 6: 201-205